BlackRock Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9.49M | Sell |
134,979
-18,420
| -12% | -$1.3M | 0.01% | 1147 |
|
|
2016
Q3 | $10.9M | Buy |
153,399
+846
| +0.6% | +$60K | 0.01% | 950 |
|
|
2016
Q2 | $7.46M | Buy |
152,553
+1,640
| +1% | +$80.2K | 0.01% | 1146 |
|
|
2016
Q1 | $9.55M | Sell |
150,913
-16,956
| -10% | -$1.07M | 0.01% | 952 |
|
|
2015
Q4 | $18.8M | Buy |
167,869
+1,140
| +0.7% | +$128K | 0.02% | 603 |
|
|
2015
Q3 | $16.1M | Buy |
166,729
+18,200
| +12% | +$1.75M | 0.02% | 651 |
|
|
2015
Q2 | $15.2M | Buy |
148,529
+99,271
| +202% | +$10.2M | 0.02% | 724 |
|
|
2015
Q1 | $3.06M | Buy |
49,258
+2,927
| +6% | +$182K | ﹤0.01% | 1729 |
|
|
2014
Q4 | $2.03M | Sell |
46,331
-93
| -0.2% | -$4.08K | ﹤0.01% | 2022 |
|
|
2014
Q3 | $2.63M | Buy |
46,424
+869
| +2% | +$49.2K | ﹤0.01% | 1791 |
|
|
2014
Q2 | $2.05M | Buy |
45,555
+26,546
| +140% | +$1.19M | ﹤0.01% | 2053 |
|
|
2014
Q1 | $929K | Buy |
+19,009
| New | +$929K | ﹤0.01% | 2539 |
|